← Evidence map

TrialPloS one2010

A phase II trial of sorafenib in metastatic melanoma with tissue correlates.

Patrick A Ott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

44 papers cite it

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

NCT00119249phase 274 enrolled2005
Full record →Abstract, authors, funding and every citing paper · PMID 21206909